These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3856430)

  • 1. Cellular transport of anthracyclines by passive diffusion. Implications for drug resistance.
    Siegfried JM; Burke TG; Tritton TR
    Biochem Pharmacol; 1985 Mar; 34(5):593-8. PubMed ID: 3856430
    [No Abstract]   [Full Text] [Related]  

  • 2. Membrane transport of anthracyclines.
    Skovsgaard T; Nissen NI
    Pharmacol Ther; 1982; 18(3):293-311. PubMed ID: 6762567
    [No Abstract]   [Full Text] [Related]  

  • 3. Modes of resistance to anthracyclines and other natural products.
    Kessel D; Romine M; Decker D
    Prog Clin Biol Res; 1986; 223():81-93. PubMed ID: 3543948
    [No Abstract]   [Full Text] [Related]  

  • 4. Mode of action of calcium antagonists which alter anthracycline resistance.
    Kessel D; Wilberding C
    Biochem Pharmacol; 1984 Apr; 33(7):1157-60. PubMed ID: 6585204
    [No Abstract]   [Full Text] [Related]  

  • 5. Facile exchange of the cyano group in highly potent anticancer cyanomorpholinyl anthracyclines.
    Peters JH; Gordon GR; Nolen HW; Tracy M; Thomas DW
    Biochem Pharmacol; 1988 Jan; 37(2):357-61. PubMed ID: 3422560
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitumor anthracyclines: recent developments.
    Arcamone F
    Med Res Rev; 1984; 4(2):153-88. PubMed ID: 6374338
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytofluorescence localization of anthracycline antibiotics.
    Egorin MJ; Clawson RE; Cohen JL; Ross LA; Bachur NR
    Cancer Res; 1980 Dec; 40(12):4669-76. PubMed ID: 6934029
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical mechanism for resistance to anthracycline antibiotics.
    Inaba M
    Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
    [No Abstract]   [Full Text] [Related]  

  • 9. Circumvention of resistance to anthracyclines by calcium antagonists and other membrane-perturbing agents.
    Kessel D
    Cancer Surv; 1986; 5(1):109-27. PubMed ID: 3297311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial conversion of epsilon-pyrromycinone to 1-hydroxy-11-deoxycarminomycin II.
    Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
    J Antibiot (Tokyo); 1985 Jun; 38(6):821-2. PubMed ID: 4019326
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions among membrane transport systems: anthracyclines, calcium antagonists and anti-estrogens.
    Kessel D
    Biochem Pharmacol; 1986 Aug; 35(16):2825-6. PubMed ID: 2943288
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of nucleosomes with anthracycline antibiotics: relevance to anticancer activity.
    Palumbo M; Cera C; Marciani-Magno S; Palù G
    Biochem Pharmacol; 1988 May; 37(9):1871-2. PubMed ID: 3163927
    [No Abstract]   [Full Text] [Related]  

  • 13. Cellular pharmacology of anthracycline resistance and its circumvention.
    Tapiero H; Fourcade A; Munck JN; Zwingelstein G; Lampidis TJ
    Drugs Exp Clin Res; 1986; 12(1-3):265-73. PubMed ID: 3460753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of resistance to anthracyclines and vinca alkaloids.
    Danø K; Skovsgaard T; Nissen NI; Friche E; Di Marco A
    Prog Clin Biol Res; 1983; 132C():231-46. PubMed ID: 6579564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of verapamil and other agents on the distribution of anthracyclines and on reversal of drug resistance.
    Hindenburg AA; Baker MA; Gleyzer E; Stewart VJ; Case N; Taub RN
    Cancer Res; 1987 Mar; 47(5):1421-5. PubMed ID: 3469017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of antineoplastic antibiotics and DNA.
    Gause GF; Dudnik YV
    Antibiot Chemother (1971); 1980; 28():102-8. PubMed ID: 6158286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical selection of new anthracyclines.
    Casazza AM
    Cancer Treat Rep; 1986 Jan; 70(1):43-9. PubMed ID: 3510737
    [No Abstract]   [Full Text] [Related]  

  • 19. Redox activities of antitumor anthracyclines determined by microsomal oxygen consumption and assays for superoxide anion and hydroxyl radical generation.
    Peters JH; Gordon GR; Kashiwase D; Lown JW; Yen SF; Plambeck JA
    Biochem Pharmacol; 1986 Apr; 35(8):1309-23. PubMed ID: 3008758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model for computer simulation of P-glycoprotein and transmembrane delta pH-mediated anthracycline transport in multidrug-resistant tumor cells.
    Demant EJ; Sehested M; Jensen PB
    Biochim Biophys Acta; 1990 Nov; 1055(2):117-25. PubMed ID: 2242381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.